Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-12-16

FDA Approved: IRINOTECAN HYDROCHLORIDE — Original Application (Sagent Pharmaceuticals)

View source ↗

Summary

FDA approves the original application for irinotecan hydrochloride (generic) from Sagent Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IRINOTECAN HYDROCHLORIDE (irinotecan hydrochloride)

Snippet

ORIG AP for IRINOTECAN HYDROCHLORIDE (IRINOTECAN HYDROCHLORIDE)